Diagnostic value of surrogate CSF biomarkers for Creutzfeldt–Jakob disease in the era of RT-QuIC

[1]  P. Calabresi,et al.  Neurofilament light chain as a biomarker in neurological disorders , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.

[2]  S. Capellari,et al.  Recent advances in the histo‐molecular pathology of human prion disease , 2019, Brain pathology.

[3]  I. Ferrer,et al.  Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease , 2019, Journal of Clinical Neuroscience.

[4]  I. Zerr,et al.  Diagnostic challenges in rapidly progressive dementia , 2018, Expert review of neurotherapeutics.

[5]  S. Capellari,et al.  Unusual Clinical Presentations Challenging the Early Clinical Diagnosis of Creutzfeldt-Jakob Disease. , 2018, Journal of Alzheimer's disease : JAD.

[6]  K. Blennow,et al.  Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases , 2018, Alzheimer's & Dementia.

[7]  P. Martinelli,et al.  The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias , 2018, Alzheimer's Research & Therapy.

[8]  J. Collinge,et al.  Imaging and CSF analyses effectively distinguish CJD from its mimics , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[9]  B. Caughey,et al.  High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions , 2017, Scientific Reports.

[10]  K. Blennow,et al.  Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology‐based cohort , 2017, European journal of neurology.

[11]  A. Green,et al.  Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels , 2017, Acta Neuropathologica.

[12]  B. Caughey,et al.  Diagnostic and prognostic value of human prion detection in cerebrospinal fluid , 2017, Annals of neurology.

[13]  B. Caughey,et al.  Extended and direct evaluation of RT‐QuIC assays for Creutzfeldt‐Jakob disease diagnosis , 2016, Annals of clinical and translational neurology.

[14]  K. Blennow,et al.  Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease , 2016, Scientific Reports.

[15]  P. Cras,et al.  Cerebrospinal fluid real‐time quaking‐induced conversion is a robust and reliable test for sporadic creutzfeldt–jakob disease: An international study , 2016, Annals of neurology.

[16]  I. Santana,et al.  Sporadic Creutzfeldt–Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay , 2016, Neuroscience.

[17]  A. Karch,et al.  Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease Diagnostic , 2016, Molecular Neurobiology.

[18]  J. Molinuevo,et al.  Clinicopathological Correlations and Concomitant Pathologies in Rapidly Progressive Dementia: A Brain Bank Series , 2015, Neurodegenerative Diseases.

[19]  K. Blennow,et al.  Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry. , 2014, JAMA neurology.

[20]  A. Bizzi,et al.  A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease , 2012, Neurology.

[21]  Mary Andrews,et al.  Real time quaking‐induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt–Jakob disease , 2012, Annals of neurology.

[22]  I. Ferrer,et al.  Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA , 2012, Acta Neuropathologica.

[23]  F. Baas,et al.  Human Prion Diseases in The Netherlands (1998–2009): Clinical, Genetic and Molecular Aspects , 2012, PloS one.

[24]  A. Green,et al.  The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt–Jakob disease in the UK: a 10-year review , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[25]  C. Begue,et al.  Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease , 2009, Brain : a journal of neurology.

[26]  B. Ghetti,et al.  Incidence and spectrum of sporadic Creutzfeldt–Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification , 2009, Acta Neuropathologica.

[27]  J. Wiltfang,et al.  Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt–Jakob disease , 2002, Neurology.

[28]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.

[29]  M. Geschwind,et al.  Differential diagnosis with other rapid progressive dementias in human prion diseases. , 2018, Handbook of clinical neurology.